Skip to content

Clinical trials

Completed Phase 1 Esophageal Squamous Cell Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 1 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20061
20071
20111
20121
20131
20163
20181
20193
20204
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
Novartis Pharmaceuticals3
Albany Medical College1
Allist Pharmaceuticals, Inc.1
AstraZeneca1
Exelixis1
Hecheng Li M.D., Ph.D1
Hoffmann-La Roche1
Incyte Corporation1
Jacobio Pharmaceuticals Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma23
Esophageal Neoplasms8
Stomach Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Squamous Cell Carcinoma of Head and Neck5
Colorectal Neoplasms4
Breast Neoplasms3
Carcinoma, Pancreatic Ductal3
Small Cell Lung Carcinoma3
Triple Negative Breast Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.